Cargando…
Long-term Follow-up for Multidrug-resistant Tuberculosis
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable lo...
Autores principales: | Shin, Sonya S., Furin, Jennifer J., Alcántara, Felix, Bayona, Jaime, Sánchez, Epifanio, Mitnick, Carole D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294679/ https://www.ncbi.nlm.nih.gov/pubmed/16704823 http://dx.doi.org/10.3201/eid1204.041256 |
Ejemplares similares
-
Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment
por: Tierney, Dylan B., et al.
Publicado: (2014) -
Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality
por: Mitnick, Carole D., et al.
Publicado: (2013) -
Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
por: Lin, Hsien-Ho, et al.
Publicado: (2012) -
The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015) -
Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
por: Tierney, Dylan B., et al.
Publicado: (2016)